584063-Bourgonje

136 References Chang, J.T. (2020). Pathophysiology of Inflammatory Bowel Diseases. N. Engl. J. Med. 383, 2652-2664. 10.1056/NEJMra2002697. Jostins, L., Ripke, S., Weersma, R.K., Duerr, R.H., McGovern, D.P., Hui, K.Y., Lee, J.C., Schumm, L.P., Sharma, Y., Anderson C.A., et al. (2012). Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature 491, 119-24. 10.1038/nature11582. de Souza, H.S.P., Fiocchi, C., and Iliopoulos, D. (2017). The IBD interactome: an integrated view of aetiology, pathogenesis and therapy. Nat. Rev. Gastroenterol. Hepatol. 14, 739-749. 10.1038/nrgastro.2017.110. Franzosa, E.A., Sirota-Madi, A., Avila-Pacheco, J., Fornelos, N., Haiser, H.J., Reinker, S., Vatanen, T., Hall, A.H., Mallick, H., McIver, L.J., et al. (2019). Gut microbiome structure and metabolic activity in inflammatory bowel disease. Nat. Microbiol. 4, 293-305. 10.1038/s41564-018-0306-4. Vich Vila, A., Imhann, F., Collij, V., Jankipersadsing, S.A., Gurry, T., Mujagic, Z., Kurilshikov, A., Bonder, M.J., Jiang, X., Tigchelaar, E.F., et al. (2018) Gut microbiota composition and functional changes in inflammatory bowel disease and irritable bowel syndrome. Sci. Transl. Med. 10, eaap8914. 10.1126/scitranslmed. aap8914. Frank, D.N., St Amand, A.L., Feldman, R.A., Boedeker, E.C., Harpaz, N., and Pace, N.R. (2007). Molecularphylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc. Natl. Acad. Sci. U. S. A. 104, 13780-5. 10.1073/pnas.0706625104. von Martels, J.Z.H., Sadaghian Sadabad, M., Bourgonje, A.R., Blokzijl, T., Dijkstra, G., Faber, K.N., and Harmsen, H.J.M. (2017). The role of gut microbiota in health and disease: In vitro modeling of hostmicrobe interactions at the aerobe-anaerobe interphase of the human gut. Anaerobe 44, 3-12. 10.1016/j. anaerobe.2017.01.001. Bischoff, S.C., Barbara, G., Buurman, W., Ockhuizen, T., Schulzke, J.D., Serino, M., Tilg, H., Watson, A., and Wells J.M. (2014). Intestinal permeability—a new target for disease prevention and therapy. BMC Gastroenterol. 14, 189. 10.1186/s12876-014-0189-7. Salim, S.Y., and Söderholm, J.D. (2011). Importance of disrupted intestinal barrier in inflammatory bowel diseases. Inflamm. Bowel. Dis. 17, 362-81. 10.1002/ibd.21403. Li, H., Limenitakis, J.P., Greiff, V., Yilmaz, B., Schären, O., Urbaniak, C., Zünd, M., Lawson, M.A.E., Young, I.D., Rupp, S., et al. (2020). Mucosal or systemic microbiota exposures shape the B cell repertoire. Nature 584, 274-8. 10.1038/s41586-020-2564-6. Pasolli, E., Asnicar, F., Manara, S., Zolfo, M., Karcher, N., Armanini, F., Beghini, F., Manghi, P., Tett, A., Ghensi, P., et al. (2019). Extensive Unexplored Human Microbiome Diversity Revealed by Over 150,000 Genomes fromMetagenomes Spanning Age, Geography, and Lifestyle. Cell 176, 649-62. 10.1016/j.cell.2019.01.001. Vogl, T., Klompus, S., Leviatan, S., Kalka, I.N., Weinberger, A., Wijmenga, C., Fu, J., Zhernakova, A., Weersma, R.K., and Segal, E. (2021). Population-wide diversity and stability of serum antibody epitope repertoires against human microbiota. Nat. Med. 27, 1442-50. 10.1038/s41591-021-01409-3. Sterlin, D., Fadlallah, J., Slack, E., and Gorochov, G. (2020). The antibody/microbiota interface in health and disease. Mucosal Immunol. 13, 3-11. 10.1038/s41385-019-0192-y. Fadlallah, J., Sterlin, D., Fieschi, C., Parizot, C., Dorgham, K., El Kafsi, H., Autaa, G., Ghillani-Dalbin, P., Juste, C., Lepage, P., et al. (2019). Synergistic convergence of microbiota-specific systemic IgG and secretory IgA. J. Allergy Clin. Immunol. 143, 1575-1585.e4. 10.1016/j.jaci.2018.09.036. Mohan, D., Wansley, D.L., Sie, B.M., Noon, M.S., Baer, A.N., Laserson, U., and Larman, H.B. (2018). PhIP-Seq characterization of serum antibodies using oligonucleotide-encoded peptidomes. Nat. Protoc. 13, 195878. 10.1038/s41596-018-0025-6. Zeevi, D., Korem, T., Zmora, N., Israeli, D., Rothschild, D., Weinberger, A., Ben-Yacov, O., Lador, D., Avnit-Sagi, T., Lotan-Pompan, M., et al. (2015). Personalized Nutrition by Prediction of Glycemic Responses. Cell 163, 1079-94. 10.1016/j.cell.2015.11.001. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 Chapter 4

RkJQdWJsaXNoZXIy MjY0ODMw